NCT00454831
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- JSS Medical Research Inc. Westmount, Quebec, Canada
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
1,809 public trials
143 recruiting studies
Dyslipidemias trial results
NCT00137462
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Huntsville, Alabama, United States
- Pfizer Investigational Site Union Grove, Alabama, United States
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
NCT00134511
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Chicoutimi, Quebec, Canada
- Pfizer Investigational Site Ste-Foy, Quebec, Canada
- Pfizer Investigational Site Parktown, Johannesburg, South Africa
NCT00405769
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +11 more
- Locations
-
- Chestnut Hill Hospital Philadelphia, Pennsylvania, United States
Completed
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
NCT00139061
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Angers, France
- Pfizer Investigational Site Bordeaux Cauderan, France
- Pfizer Investigational Site Briollay, France
NCT00134485
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
- Locations
-
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Washington D.C., District of Columbia, United States
- Pfizer Investigational Site Lutz, Florida, United States
- Pfizer Investigational Site Tampa, Florida, United States
NCT00546182
- Conditions
- Dyslipidemias, Glucose Metabolism Disorders, Hypercholesterolemia, +6 more
- Locations
-
- Gil Medical Center, Gachon University Incheon, South Korea
Completed
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
NCT00195793
- Conditions
- Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
- Locations
-
Not specified
Completed
Antioxidant Functions of Lipoic Acid
NCT00065624
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT00069524
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +17 more
- Locations
-
- General Clinical Research Center, San Francisco General Hospital San Francisco, California, United States